<DOC>
	<DOCNO>NCT00291525</DOCNO>
	<brief_summary>Various patient group On-X Valve maintain safely low dos blood thinner ( Coumadin® ) antiplatelet drug ( aspirin/Plavix® ) rather standard dose Coumadin aspirin presently recommend ACC/AHA ACCP professional society .</brief_summary>
	<brief_title>Randomized On-X Anticoagulation Trial</brief_title>
	<detailed_description>This longitudinal , randomize ( randomization occur 3 month follow-up ) study compare On-X valve low dose anticoagulation ( test group ) concomitant control group On-X valve receive standard Coumadin/aspirin therapy , also FDA objective performance criterion ( OPC ) heart valve replacement . It multicenter study consist 20 center United States enrol 1200 patient ( 200 6 group ) . There three test arm study : low risk aortic valve replacement , high risk aortic valve replacement mitral valve replacement . Each arm equivalent control . Test therapy : low risk aortic valve replacement - aspirin/Plavix , high risk aortic valve replacement - Coumadin INR 1.5 2.0 plus aspirin , mitral valve replacement - Coumadin INR 2.0 2.5 plus aspirin . Follow-up run 5 year patient .</detailed_description>
	<mesh_term>Heart Valve Diseases</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Patients require isolated aortic valve replacement ( AVR ) , isolated mitral valve replacement ( MVR ) . AVR patient receive low dose antiplatelet anticoagulation divide group low risk high risk thromboembolism patient low risk group except patient follow condition place patient high risk group : Chronic atrial fibrillation Left ventricular ejection fraction &lt; 30 % Enlarged leave atrium &gt; 50mm diameter Spontaneous echo contrast leave atrium Vascular pathology Neurological event Hypercoagulability Left right ventricular aneurysm Lack platelet response aspirin clopidogrel Women receive estrogen replacement therapy Concomitant cardiac surgery allow Adult patient Right side valve replacement Double ( aortic plus mitral ) valve replacement Patients active endocarditis time implant Previous confirm suspect thromboembolic event thrombophlebitis Other terminal illness Patients emergency state Inability return require followup Patients OnX valve implant within study subsequently explanted Patients know pregnant , plan become pregnant lactating Patients acquire immunodeficiency syndrome know HIV positive Patients prison inmate know drug alcohol abuser Patients unable give adequate inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>valve</keyword>
	<keyword>prosthesis</keyword>
	<keyword>antithrombotics</keyword>
	<keyword>randomize</keyword>
</DOC>